Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis
- PMID: 17324770
- DOI: 10.1016/j.jamcollsurg.2006.12.019
Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis
Abstract
Background: Although established for metastatic colorectal (CR) and neuroendocrine (NE) malignancies, the role of partial hepatectomy in management of metastases from other primaries (NCRNE) is not well-defined.
Study design: The objective of this retrospective study is to compare outcomes after partial hepatectomy for NCRNE, NE, and CR metastases and to identify factors associated with longterm survival for patients with NCRNE diseases. Tumor characteristics, treatments, and outcomes of 360 consecutive patients undergoing resection of NCRNE (n = 82), CR (n = 245), and NE (n = 33) hepatic metastases from 1995 to 2005 were analyzed. NCRNE tumors included breast (n = 20), sarcomas (n = 19), genitourinary (n = 18), melanoma (n = 11), and other (n = 14) cancers. The start date for follow-up and survival analyses was the date of partial hepatectomy.
Results: For patients with NCRNE, CR, and NE tumors, there were no marked differences in postoperative mortality (4%, 4%, and 9%) or complication (30%, 42%, and 42%) rates. Median overall survival was longest for NE patients (not yet reached) versus NCRNE and CR (both 44 months) patients (p < 0.05, log-rank test). NCRNE patients had shorter disease-free survival than CR counterparts (13 versus 16 months), p < 0.05 (log-rank test). After median followup of 59 months for NCRNE patients, actuarial 5-year overall and disease-free survival was 37% and 16%, respectively, with 15 5-year survivors. Multivariable analysis suggests that interval from discovery of liver metastases to resection > 6 months (p = 0.08) and administration of chemoradiotherapy after resection (p = 0.06) might be associated with improved overall survival.
Conclusions: In selected patients, resection of NCRNE liver metastases can be done safely with survival similar to CR metastases. Delay of liver resection for at least 6 months and treatment with chemoradiotherapy after resection might be associated with improved longterm survival after partial hepatectomy.
Similar articles
-
Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review.Ann Surg Oncol. 2005 Oct;12(10):778-85. doi: 10.1245/ASO.2005.11.018. Epub 2005 Aug 18. Ann Surg Oncol. 2005. PMID: 16132374
-
Hepatic resection of noncolorectal nonneuroendocrine metastases.Liver Transpl. 2000 Jan;6(1):97-101. doi: 10.1002/lt.500060114. Liver Transpl. 2000. PMID: 10648585
-
Partial hepatic resection for liver metastases of non-colorectal origin, is it justified?Hepatogastroenterology. 2007 Jul-Aug;54(77):1517-21. Hepatogastroenterology. 2007. PMID: 17708288
-
Resection of liver metastases from breast cancer: towards a management guideline.Int J Surg. 2011;9(4):285-91. doi: 10.1016/j.ijsu.2011.01.009. Epub 2011 Jan 31. Int J Surg. 2011. PMID: 21281746 Review.
-
Hepatectomy for metastatic noncolorectal gastrointestinal, breast and testicular tumours.ANZ J Surg. 2006 Apr;76(4):246-50. doi: 10.1111/j.1445-2197.2006.03689.x. ANZ J Surg. 2006. PMID: 16681543 Review.
Cited by
-
Surgical treatment of neuroendocrine liver metastases.Int J Hepatol. 2012;2012:146590. doi: 10.1155/2012/146590. Epub 2012 Jan 26. Int J Hepatol. 2012. PMID: 22319650 Free PMC article.
-
Effects of different metastasis patterns, surgery and other factors on the prognosis of patients with stage IV non-small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) linked database analysis.Oncol Lett. 2019 Jul;18(1):581-592. doi: 10.3892/ol.2019.10373. Epub 2019 May 20. Oncol Lett. 2019. PMID: 31289530 Free PMC article.
-
Liver resection for non-colorectal, non-carcinoid, non-sarcoma metastases: a multicenter study.PLoS One. 2015 Mar 26;10(3):e0120569. doi: 10.1371/journal.pone.0120569. eCollection 2015. PLoS One. 2015. PMID: 25811923 Free PMC article.
-
Surgery for liver metastases originating from sarcoma-case series.Langenbecks Arch Surg. 2011 Oct;396(7):1083-91. doi: 10.1007/s00423-011-0821-8. Epub 2011 Jul 8. Langenbecks Arch Surg. 2011. PMID: 21739304
-
Liver Resection for Non-colorectal Non-neuroendocrine Metastases: Where Do We Stand Today Compared to Colorectal Cancer?J Gastrointest Surg. 2016 Jun;20(6):1163-72. doi: 10.1007/s11605-016-3115-1. Epub 2016 Feb 26. J Gastrointest Surg. 2016. PMID: 26921025
MeSH terms
LinkOut - more resources
Full Text Sources
Medical